Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer

Primary systemic therapy (PST) for operable breast cancer enables the identification of in vivo biological markers that predict response to treatment. A total of 118 patients with T2–4 N0–1 M0 primary breast cancer received six cycles of anthracycline-based PST. Clinical and radiological response wa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Burcombe, R J, Makris, A, Richman, P I, Daley, F M, Noble, S, Pittam, M, Wright, D, Allen, S A, Dove, J, Wilson, G D
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2005
Assuntos:
Molecular Diagnostics
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2361750/
https://ncbi.nlm.nih.gov/pubmed/15611798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6602256
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados